Fintel on MSN

Inovio Pharmaceuticals (INO) price target increased by 12.14% to 8.73

The average one-year price target for Inovio Pharmaceuticals (NasdaqCM:INO) has been revised to $8.73 / share. This is an ...

INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And Risk

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

Inovio Extends Series A Warrants, Enhancing Capital Flexibility

The latest announcement is out from Inovio Pharmaceuticals ( (INO) ).

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

Shares of Inovio Pharmaceuticals Inc. INO rose 5.23% to $1.61 Thursday, on what proved to be an all-around mixed trading ...

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors

This was the stock's second consecutive day of losses.
Morningstar

FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from ...